UK markets closed

IDEXX Laboratories, Inc. (IDXX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
651.13+5.89 (+0.91%)
As of 12:32PM EDT. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 554.30B
Enterprise value 355.08B
Trailing P/E 75.70
Forward P/E 172.46
PEG ratio (5-yr expected) 16.18
Price/sales (ttm)18.10
Price/book (mrq)72.29
Enterprise value/revenue 318.08
Enterprise value/EBITDA 757.14

Trading information

Stock price history

Beta (5Y monthly) 0.95
52-week change 350.17%
S&P500 52-week change 331.29%
52-week high 3706.95
52-week low 3419.12
50-day moving average 3648.19
200-day moving average 3614.89

Share statistics

Avg vol (3-month) 3382.97k
Avg vol (10-day) 3273.49k
Shares outstanding 585.08M
Implied shares outstanding 6N/A
Float 884.21M
% held by insiders 10.94%
% held by institutions 187.70%
Shares short (29 Sept 2021) 4793.88k
Short ratio (29 Sept 2021) 41.69
Short % of float (29 Sept 2021) 41.06%
Short % of shares outstanding (29 Sept 2021) 40.93%
Shares short (prior month 30 Aug 2021) 41.05M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 315 Jun 2015

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021


Profit margin 23.89%
Operating margin (ttm)28.35%

Management effectiveness

Return on assets (ttm)24.69%
Return on equity (ttm)142.55%

Income statement

Revenue (ttm)3.05B
Revenue per share (ttm)35.67
Quarterly revenue growth (yoy)29.60%
Gross profit (ttm)1.57B
EBITDA 963.47M
Net income avi to common (ttm)727.85M
Diluted EPS (ttm)8.39
Quarterly earnings growth (yoy)36.00%

Balance sheet

Total cash (mrq)232.13M
Total cash per share (mrq)2.73
Total debt (mrq)1.01B
Total debt/equity (mrq)135.34
Current ratio (mrq)1.54
Book value per share (mrq)8.78

Cash flow statement

Operating cash flow (ttm)770.43M
Levered free cash flow (ttm)588.37M